Zimbabwe has declined a substantial US health deal worth 367 million US dollars (272 million pounds) spanning five years because of the United States' demand for sensitive biological samples.
The decision became public following a official document from December was disclosed, which showed President Emmerson Mnangagwa deemed the deal was "unbalanced".
An official spokesman has since explained that the US was requesting biological samples for scientific study and commercial gain but was unwilling to guarantee the benefits from future vaccines.
"We are forced to start the difficult and regrettable task of winding down our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had donated more than $1.9bn as health assistance to Zimbabwe during the past two decades.
A medical body in Zimbabwe has urged further negotiations to secure a deal suitable to all parties so the country's vital HIV programme can continue.
Broader Context
This rejection follows a similar case in neighbouring Kenya, where a court blocked a similar health funding agreement following legal challenges were raised about the safety of Kenyans' health data.
Since returning to the presidency last year, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.
USAID had administered aid for the US government, but Trump stated its spending was "inefficient" and his administration was seeking government-to-government agreements to boost transparency and accountability.
As per reports, 16 nations in Africa have so far signed similar health pacts, representing more than $18.3bn of fresh investment.
Details of the Declined Agreement
This assistance for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this collaboration would have delivered immense benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently on antiretroviral therapy via US-supported programmes," Tremont added.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"The proposal required Zimbabwe to share its biological resources and data for a long time, without any equivalent promise of access to any medical innovations – like new medicines or tests – that could be developed from that provided information," his statement read.
"In essence, our nation would supply the raw materials for scientific discovery without any certainty that the final treatments would be accessible to our population if a future pandemic arise."
National Interest and International Frameworks
Mangwana further noted that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining structures previously set up via the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system created to deal with future global health emergencies.
"This framework is intended to guarantee that when a nation provides its samples, the benefits – including medicines and cures – are distributed fairly, not monopolised solely by those with the resources to develop them."
The government's concerns regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We encourage further dialogue with our American counterparts on how subsequent collaboration might be structured in a way that honours the independence and dignity of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the official position, but urged that talks should continue given that a large portion of the nation's HIV programmes depended on external financing.
"If specific concerns exist, including those relating to data governance or implementation frameworks, these can frequently be resolved through detailed discussion and negotiated safeguards," the group added.
The situation highlights the continuing challenges between accepting vital international aid and protecting national sovereignty in an ever more interconnected world.